This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Diabetes, Metabolic Syndrome And Cardiovascular Disease

Table 8.2: Categories of Increased Risk for Diabetes (Pre-Diabetes) 159

Table 8.3: Laboratory Assessment of Diabetic Vascular Disease 163

Table 8.4: Worldwide Glucose Self-Testing Market Sales (Meters and Strips), 2010-2016 163

Table 8.5: Market for Glucose Self-Testing in the U.S. (includes Meters, Strips, and Lancets), 2010-2016 164

Table 8.6: Market Share of U.S. Blood Glucose Self-Testing, 2011 164

Table 8.7: Lancet Characteristics 179

Table 9.1: BRIC countries, Percentage of GDP Spent on Healthcare, 2008 185

Table 9.2: Summary of Emerging Non-Insulin Anti-Diabetes Drug Categories 186

Table 9.3: Selected Diabetes Drugs in Clinical Trials, 2011 186

Table A1.1: Select Archived Press Release Excerpts 218

To order this report: Pathology Industry: Diabetes, Metabolic Syndrome and Cardiovascular Disease

ContactNicolas BombourgReportlinkerEmail: nicolasbombourg@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626


SOURCE Reportlinker

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
9 of 9

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.11 -0.63%
FB $103.21 1.30%
GOOG $687.64 0.66%
TSLA $146.99 -2.30%
YHOO $26.77 0.04%


Chart of I:DJI
DOW 15,747.26 +87.08 0.56%
S&P 500 1,842.82 +13.74 0.75%
NASDAQ 4,293.8510 +27.0140 0.63%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs